Study of Azeliragon in Patients With Mild Alzheimer's Disease and Impaired Glucose Tolerance

PHASE2TerminatedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

June 27, 2019

Primary Completion Date

December 1, 2020

Study Completion Date

January 29, 2021

Conditions
Alzheimer Disease
Interventions
DRUG

Azeliragon

Azeliragon 5 mg capsule administered orally, once daily

DRUG

Placebo

Matching placebo capsule administered orally, once daily

Trial Locations (33)

11042

Neurological Associates of Long Island, Lake Success

13057

Clarity Clinical Research, East Syracuse

27157

Wake Forest School of Medicine, Winston-Salem

27607

Raleigh Neurology Associates, Raleigh

28270

ANI Neurology dba Alzheimer's Memory Center, Charlotte

30033

NeuroStudies.net LLC, Decatur

30329

Emory Alzheimer's Clinical Research Unit, Atlanta

32127

Progressive Medical Research, Port Orange

32159

Charter Research, Lady Lake

32216

Jacksonville Center for Clinical Research, Jacksonville

32514

Emerald Coast Center for Neurological Disorders, Pensacola

32751

ClinCloud, Maitland

32806

Synexus Clinical Research US, Orlando

33445

Brain Matters Research, Delray Beach

33449

Alzheimer's Research and Treatment Center, Lake Worth

33462

JEM Research Institute, Atlantis

34243

The Roskamp Institute, Sarasota

34997

Brain Matters Research, Stuart

39401

Memory Center / Hattiesburg Clinic, Hattiesburg

43210

The Ohio State University, Columbus

46202

IU Health Partners, Adult Neurology Clinic, Indianapolis

63132

Millennium Psychiatric Associates, St Louis

85710

Tucson Neuroscience Research, Tucson

97210

Summit Research Network, Portland

97225

Center for Cognitive Health, Portland

06510

Institute for Neurodegenerative Disorders, New Haven

07081

The Cognitive and Research Center of New Jersey, Springfield

V1Y 1Z9

Okanagan Clinical Trials Ltd., Kelowna

B3S 1M7

True North Clinical Research Inc., Halifax

B4N 4K9

True North Clinical Research Inc., Kentville

K1Z IG3

Recherches Neuro-Hippocampe, Ottawa

J8T 8J1

Recherches Neuro-Hippocampe Inc., Gatineau

J1J 2G2

Q&T Research Sherbrooke Inc, Sherbrooke

Sponsors

Lead Sponsor

All Listed Sponsors
lead

vTv Therapeutics

INDUSTRY